Ikarian Capital LLC 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 4:32 pm Sale | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Ikarian Capital LLC | 1,364,990 3.500% | -227,449 (-14.28%) | Filing |
| 2020-06-18 09:11 am Purchase | 2020-06-10 | 13G | Celldex Therapeutics, Inc. CLDX | Ikarian Capital LLC | 1,592,439 7.100% | 1,592,439 (New Position) | Filing |